U.S. Urinary Incontinence Therapeutics Market Size & Outlook
Related Markets
U.S. urinary incontinence therapeutics market highlights
- The U.S. urinary incontinence therapeutics market generated a revenue of USD 1,550.3 million in 2024 and is expected to reach USD 2,414.5 million by 2033.
- The U.S. market is expected to grow at a CAGR of 5.1% from 2025 to 2033.
- In terms of segment, stress incontinence was the largest revenue generating type in 2024.
- Urge Incontinence is the most lucrative type segment registering the fastest growth during the forecast period.
Urinary incontinence therapeutics market data book summary
| Market revenue in 2024 | USD 1,550.3 million |
| Market revenue in 2033 | USD 2,414.5 million |
| Growth rate | 5.1% (CAGR from 2025 to 2033) |
| Largest segment | Stress incontinence |
| Fastest growing segment | Urge Incontinence |
| Historical data | 2021 - 2023 |
| Base year | 2024 |
| Forecast period | 2025 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Stress Incontinence, Urge Incontinence, Overflow Incontinence, Functional Incontinence, Other |
| Key market players worldwide | Pfizer Inc, AbbVie Inc, Astellas Pharma Inc, Johnson & Johnson, Viatris Inc, Teva Pharmaceutical Industries Ltd, Sanofi SA, GlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Boehringer Ingelheim Pharma, Bayer AG, Ferring |
Other key industry trends
- In terms of revenue, U.S. accounted for 35.9% of the global urinary incontinence therapeutics market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In North America, U.S. urinary incontinence therapeutics market is projected to lead the regional market in terms of revenue in 2033.
- Mexico is the fastest growing regional market in North America and is projected to reach USD 78.2 million by 2033.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Urinary Incontinence Therapeutics Market Scope
Urinary Incontinence Therapeutics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Boehringer Ingelheim Pharma | View profile | 10001+ | Dortmund, Nordrhein-Westfalen, Germany, Europe | https://www.boehringer-ingelheim.de/unternehmensprofil/unser-unternehmen/standort-dortmund |
| GlaxoSmithKline | View profile | 10001+ | London, England, United Kingdom, Europe | http://www.gsk.com |
| GlaxoSmithKline Consumer Healthcare (GSK CH India) | View profile | 1001-5000 | Gurgaon, Haryana, India, Asia | https://india-consumer.gsk.com/ |
| Astellas Pharma Inc | View profile | 14484 | 2-5-1, Nihonbashi-Honcho, Chuo-ku, Tokyo, Japan, 103-8411 | http://www.astellas.com |
| Ferring | View profile | 5001-10000 | Saint-prex, Vaud, Switzerland, Europe | https://www.ferring.com |
| Viatris Inc | View profile | 38000 | 1000 Mylan Boulevard, Canonsburg, PA, United States, 15317 | https://www.viatris.com |
| Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
| Sanofi SA | View profile | 87994 | 46, avenue de la Grande Armée, Paris, France, 75017 | https://www.sanofi.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
U.S. urinary incontinence therapeutics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to urinary incontinence therapeutics market will help companies and investors design strategic landscapes.
Stress incontinence was the largest segment with a revenue share of 31.57% in 2024. Horizon Databook has segmented the U.S. urinary incontinence therapeutics market based on stress incontinence, urge incontinence, overflow incontinence, functional incontinence, other covering the revenue growth of each sub-segment from 2021 to 2033.
Reasons to subscribe to U.S. urinary incontinence therapeutics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. urinary incontinence therapeutics market databook
-
Our clientele includes a mix of urinary incontinence therapeutics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. urinary incontinence therapeutics market , including forecasts for subscribers. This country databook contains high-level insights into U.S. urinary incontinence therapeutics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. urinary incontinence therapeutics market size, by type, 2021-2033 (US$M)
U.S. Urinary Incontinence Therapeutics Market Outlook Share, 2024 & 2033 (US$M)
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
